INNERDYNE INC
SC 14D9/A, 2000-11-22
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: INNOVET INC, 10QSB, EX-27, 2000-11-22
Next: GOLDMAN SACHS TRUST, 485APOS, 2000-11-22



  As filed with the Securities and Exchange Commission on November 21, 2000
================================================================================

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                 ---------------
                               AMENDMENT TO NO. 2
                                       TO
                                 SCHEDULE 14D-9
                                 (RULE 14D-101)

         SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14 (d) (4)
                     OF THE SECURITIES EXCHANGE ACT OF 1933

                                 ---------------

                                 INNERDYNE, INC.
                            (Name of Subject Company)

                                 INNERDYNE, INC.
                      (Name of Person(s) Filing Statement)


                                    45764D102
                      (CUSIP Number of Class of Securities)

                              1244 Reamwood Avenue
                               Sunnyvale, CA 94089
                                 (408) 745-6010
    (Address, including zip code, and telephone number, including area code,
                  of Registrant's principal executive offices)

                                 ---------------

                                William G. Mavity
                      President and Chief Executive Officer
                                 InnerDyne, Inc.
                              1244 Reamwood Avenue
                               Sunnyvale, CA 94089
                                 (408) 745-6010
   (Name, Address and telephone Number of Person Authorized to Receive Notices
                                       and
           Communications on Behalf of the Person(s) Filing Statement)

                                 ---------------

                                    Copy to:
                              Alan Talkington, Esq.
                         Orrick, Herrington & Sutcliffe
                                       LLP
                               400 Sansome Street
                             San Francisco, CA 94111
                                 (415) 392-1122
                                 ---------------
  |_| Check the box if the filing relates solely to preliminary communications
                 made before the commencement of a tender offer.

================================================================================

<PAGE>

The purpose of this  Amendment  No. 2 is to amend and  supplement  Item 9 of the
Schedule  14D-9 as described  below.  Defined  terms used herein and not defined
have the meanings given them in the Schedule 14D-9 previously filed.


ITEM   9.   EXHIBITS.

Item 9 is amended and  supplemented as set forth below.  The remainder of Item 9
as previously filed is incorporated herein by reference.

(a)(7)   Joint Press Release of InnerDyne, Inc. and Tyco International Ltd.,
         dated November 21, 2000.

<PAGE>

                                    SIGNATURE

      After  reasonable  inquiry and to the best of my knowledge  and belief,  I
certify that the information  set forth in this statement is true,  complete and
correct.

Dated:  November 21, 2000

                                          InnerDyne, Inc.


                                          By:      /s/ William G. Mavity
                                               -------------------------------
                                          Name:  William G. Mavity
                                          Title: President and Chief
                                                 Executive Officer


                                       2
<PAGE>

                                                                EXHIBIT (a)(6)

                          FTC GRANTS EARLY TERMINATION
                          FOR INNERDYNE EXCHANGE OFFER

PEMBROKE, Bermuda and SUNNYVALE, Calif., Nov. 21 -- Tyco International Ltd.
(NYSE: TYC; LSE: TYI; BSX: TYC), a diversified manufacturing and service
company, and InnerDyne, Inc. (Nasdaq: IDYN), a medical manufacturer and
distributor of patented radial dilating access devices used in minimally
invasive surgical procedures, today announced that the Federal Trade
Commission has granted early termination of the waiting period under the
Hart-Scott-Rodino Act relating to the exchange offer of Tyco Acquisition
Corp. X for the common stock of InnerDyne.

Tyco  Acquisition  is offering  to  exchange a fraction  of a Tyco common  share
valued at $7.50,  determined as described in the prospectus  for the offer,  for
each share of InnerDyne  common stock. The offer is scheduled to expire at 12:00
midnight on Wednesday, November 29, 2000.

ABOUT INNERDYNE

InnerDyne designs,  develops and manufactures minimally invasive surgical access
products that incorporate the company's  proprietary radial dilation technology,
including  the patented  Step(TM)  expandable  needle  system.  Radial  dilation
provides  surgical  access  through  expansion  of a very  small  opening  using
progressively larger blunt instruments.

ABOUT TYCO INTERNATIONAL

Tyco is a diversified  manufacturing  and service  company.  Tyco is the world's
largest manufacturer and servicer of electrical and electronic  components;  the
world's  largest  designer,  manufacturer,  installer  and  servicer of undersea
telecommunications  systems;  the world's  largest  manufacturer,  installer and
provider of fire protection systems and electronic  security  services,  and the
world's  largest  manufacturer  of flow control  valves.  Tyco also holds strong
leadership  positions in disposable medical products,  diagnostic imaging,  bulk
pharmaceuticals,  wound closure,  plastics and adhesives.  Tyco operates in more
than 100 countries  and has reported  fiscal 2000 sales of  approximately  $28.9
billion.

Tyco  has  filed a  registration  statement  on  Form  S-4,  a  Schedule  TO,  a
preliminary  prospectus and other  documents  relating to the exchange offer and
InnerDyne  has  filed  the  related  solicitation/recommendation   statement  on
Schedule 14D-9 with the SEC. Copies of these documents and other documents filed
by Tyco and  InnerDyne  with the SEC may be  obtained  at the  SEC's web site at
http://www.sec.gov.  These  documents  may also be  obtained  from  Tyco or from
InnerDyne by directing requests to Tyco  International  Ltd., The Zurich Centre,
Second Floor, 90 Pitts Bay Road,  Pembroke HM 08, Bermuda,  tel: (441) 292-8674;
or to InnerDyne,  Inc., 1244 Reamwood Avenue,  Sunnyvale,  CA 94089,  tel: (408)
745-6010.

Documents may also be obtained from MacKenzie  Partners,  Inc., the  information
agent for the offer, 156 Fifth Avenue,  New York, New York 10010, (212) 929-5500
(call collect) or (800) 322-2885 (toll free).



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission